GNH USA

Europe — EMA

Lactulose Mip

GNH USA supplies Lactulose Mip (Lactulose), an osmotic laxative for constipation and hepatic encephalopathy. Request a quote for global supply.

Lactulose

Request sourcing

1
Pack/s

What is Lactulose?

Lactulose, the active ingredient in Lactulose Mip, is an osmotic laxative presented as an oral solution for oral use. It treats constipation and hepatic encephalopathy in adult patients, helping to restore normal bowel function and reduce blood ammonia levels.

GNH USA supplies Lactulose Mip as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Lactulose used for?

Lactulose is an osmotic laxative used in gastrointestinal and hepatic conditions. - Constipation: softens stools and promotes regular bowel movements by drawing water into the colon. - Hepatic encephalopathy: lowers intestinal ammonia production and absorption, helping to improve neurological symptoms in patients with liver disease.

What are the side effects of Lactulose?

Lactulose may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Abdominal cramping: mild to moderate discomfort in the abdomen. - Flatulence: increased intestinal gas. - Diarrhea: loose stools, especially at higher doses. - Nausea: feeling of unease or urge to vomit. - Bloating: sensation of fullness. - Thirst: increased desire for fluids.

Serious or Rare Side Effects: - Severe electrolyte imbalance: abnormal sodium or potassium levels. - Dehydration: excessive fluid loss leading to low blood volume. - Allergic reaction: rash, itching, or swelling. - Severe abdominal pain: intense, persistent pain. - Hypernatremia: elevated blood sodium concentration. - Persistent diarrhea: lasting more than a few days and causing weakness.

What precautions apply to Lactulose?

When prescribing Lactulose, clinicians should consider patient‑specific factors and monitor for potential risks. - Dose titration: adjust the dose gradually to achieve the desired stool consistency. - Renal impairment: monitor kidney function, as altered fluid balance may affect renal clearance. - Electrolyte monitoring: check serum electrolytes regularly, especially in elderly or frail patients. - Diabetes mellitus: consider carbohydrate content if the formulation contains sugars. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

What does Lactulose interact with?

Lactulose can interact with other medicines, altering their absorption or effect.

Major Interactions (Avoid): - Antacids containing magnesium or aluminum: may reduce Lactulose efficacy by binding. - Antibiotics: broad‑spectrum agents can disrupt gut flora, potentially diminishing Lactulose metabolism.

Moderate Interactions (Monitor Closely): - Diuretics: increased risk of electrolyte disturbances. - Insulin or oral hypoglycemics: carbohydrate content may affect blood glucose control. - Other laxatives: additive effect may cause severe diarrhea. - Oral phosphate binders: may interfere with Lactulose’s osmotic action.

Frequently asked questions

What is Lactulose Mip used for?+
Lactulose Mip is used to treat constipation by softening stools and to manage hepatic encephalopathy by reducing ammonia absorption in the intestines. It helps restore regular bowel movements and improves neurological symptoms in patients with liver disease.
How does Lactulose work in the body?+
Lactulose is a synthetic sugar that reaches the colon unchanged, where gut bacteria ferment it into short‑chain fatty acids. This creates an osmotic gradient that draws water into the colon, softening stools, and the resulting acidic environment lowers ammonia production, benefiting patients with hepatic encephalopathy.
What is the usual dose of Lactulose Mip?+
The dose of Lactulose Mip is individualized by the prescribing clinician based on the patient’s condition, response, and tolerance. Dosage adjustments are made to achieve the desired stool consistency or ammonia reduction, and the prescriber determines the exact regimen.
Is Lactulose safe to use during pregnancy or breastfeeding?+
Safety data for Lactulose in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.
How do I order Lactulose Mip from GNH USA?+
To order Lactulose Mip, submit an enquiry on the product page at gnh-usa.com with the required quantity. GNH USA supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Lactulose compare with other laxatives?+
Lactulose is an osmotic laxative that works by increasing water content in the colon, unlike stimulant laxatives that trigger intestinal muscle contractions. It also has the added benefit of lowering ammonia levels, a property not shared by most other laxatives, making it useful for hepatic encephalopathy.
What are the storage and handling requirements for Lactulose Mip?+
Lactulose Mip should be stored at ambient temperature, below 25 °C, in its original packaging. Protect it from moisture, direct sunlight, and extreme temperatures to maintain product stability and potency.
How is Lactulose Mip administered?+
Lactulose Mip is taken orally, usually as a measured dose of the liquid solution. It can be mixed with water or another beverage if needed, and should be consumed according to the prescribing clinician’s instructions.
What are the most serious risks associated with Lactulose?+
Serious risks include severe electrolyte imbalance, dehydration, and rare allergic reactions. Patients should be monitored for signs of excessive diarrhea, weakness, or abnormal blood chemistry, and seek medical attention if these occur.
Who should not use Lactulose Mip?+
Lactulose Mip is contraindicated in patients with known hypersensitivity to lactulose or any component of the formulation. Caution is advised in individuals with severe renal impairment, intestinal obstruction, or those at high risk for electrolyte disturbances.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Lactulose
Route
Oral Use
Manufacturer
Mip Pharma Gmbh
Origin
EU

Related products